NBIX Kevin Charles Gorman sells $13.4M worth of shares
Aug 12, 2025, 4:34 AM
0.00%
What does NBIX do
Neurocrine Biosciences, based in San Diego, develops pharmaceuticals for neurological disorders and employs 1,448 people. Its FDA-approved products include INGREZZA and Orilissa, with a strong clinical development pipeline.
Kevin Charles Gorman sold 106,322 shares of NBIX on 7 August at $126.41 per share, worth a total of $13.4M. They now own 514,596 NBIX shares, or a 17% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
